hs-CRP Cancer Research Results
hs-CRP, High-sensitivity C-reactive protein: Click to Expand ⟱
| Source: |
| Type: biomarker |
High-sensitivity C-reactive protein (hs-CRP) is a biomarker that measures inflammation in the body. Research has shown that elevated levels of hs-CRP are associated with an increased risk of various types of cancer.
• hs-CRP:
+ Normal: < 1 mg/L
+ Elevated: 1-3 mg/L (may indicate chronic inflammation)
+ High: > 3 mg/L (may indicate increased cardiovascular risk or chronic inflammation)
|
Scientific Papers found: Click to Expand⟱
*hs-CRP↓, *TNF-α↓, *SOD↑, *Catalase↑, *GPx↑, *cognitive↑, *memory↑, *Risk↓, *SAM-e↑, *NAD↝, *ATP↝, *Ca+2↝, HDAC↓, TumVol↓, IGF-1↓, PSA↓, Cyc↓, TumCMig↓, *serineP↓, HIF-1↓, *ChemoSideEff↓, *VitD↑, *Mag↑, *Synergy↑, Risk↓, *Inflam↓, *neuroP↑, *Calcium↑, *BMD↑, *chemoP↑, AntiCan↑, *Dose↑, *Dose↝, *BMPs↑, *testos↑, angioG↓, Apoptosis↑, *selectivity↑, *chemoPv↑,
*hs-CRP↓, *TNF-α↓, *SHBG↓, *DHT↑, *cortisol↑, *VitD↑, *BioAv↑, *Inflam↓,
*Dose?, *TAC↑, *VCAM-1↓, *hs-CRP↓, *cardioP↑,
*Ingr↝, *cardioP↑, *LDL↓, *lipidLev↓, *AntiDiabetic↑, *hepatoP↑, *AntiCan↑, *Analgesic↑, *AntiArt↑, *CRP↓, *TNF-α↓, *Inflam↓, *toxicity↝, *neuroP↑, *Ingr↝, *Ingr↝, *AntiViral↑, Risk↓, *Ingr↝, *hs-CRP↓, *GutMicro↑, *TJ↑, *OCLN↝, *MLC2/MYL9↝, *VCAM-1↓, *Akt2↓, *IKKα↓, *NF-kB↓, Synergy↑, HER2/EBBR2↓, MAPK↓, PI3K↓, Akt↓, EGFR↓, TumCG↓, TumMeta↓, IGF-1↓, COX2/PTGS2↓, PGE2↓, CDK4↓, TNF-α↓, IL1β↓, lipid-P↑, P53↑, MDM2↑, cl‑Casp3↑, cl‑PARP↑, cl‑Casp7↑, BAX↑, Bcl-2↓, Bax:Bcl2↑, Cyt‑c↑, Casp9↑, Ki-67↓, CYP1A1↑, p38↑, ERK↑, Synergy↑, ChemoSen↑, *BioAv↑, eff↝, Ingr↝,
*cardioP↑, *Obesity↓, *lipidLev↓, *BP↓, *Inflam↓, *CRP↓, *IL6↓, *ROS↓, *hepatoP↑, *Ingr↝, *GutMicro↑, *Dose↑, *Ingr↝, *Ingr?, *CompStab↝, *MDA↓, *hs-CRP↓, *TNF-α↓, *AntiDiabetic↑, *ALAT↓, *AST↓, *GGT/CD224↓, *TG/TAG↓, *LDL↓, *HDL∅, *TC↓, *glucose↓, *Insulin↓, *SIRT1↑, *Dose↝, *Dose?,
*lipidLev↓, *BP↓, *HOMA↓, *AntiCan↑, *antiOx↑, *BioAv↑, *Ingr↑, *Ingr↝, *Ingr↝, *GutMicro↑, *CompStab↝, *TC↓, *TG/TAG↓, *LDL↓, *HDL↑, *BP↓, *AntiDiabetic↑, *AntiCan↑, TumCD↑, selectivity↑, TumCP↓, Apoptosis↑, DNAdam↑, i-ROS↑, TumCCA↑, CDK2↓, CDK4↓, cycD1/CCND1↓, cycE/CCNE↓, ChemoSen↑, Synergy↑, *Inflam↓, *hs-CRP↓, *VCAM-1↓, *BDNF↑,
*Dose↝, *hs-CRP↓,
Showing Research Papers: 1 to 7 of 7
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 7
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
lipid-P↑, 1, i-ROS↑, 1,
Cell Death(tgid=5) ⓘ
Apoptosis↑, 2, BAX↑, 1, Bax:Bcl2↑, 1, Bcl-2↓, 1, cl‑Casp3↑, 1, cl‑Casp7↑, 1, Casp9↑, 1, Cyt‑c↑, 1, MDM2↑, 1, p38↑, 1, TumCD↑, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
Akt↓, 1, EGFR↓, 1, ERK↑, 1, HER2/EBBR2↓, 1, MAPK↓, 1, PI3K↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
HDAC↓, 1,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↑, 1, P53↑, 1, cl‑PARP↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK2↓, 1, CDK4↓, 2, Cyc↓, 1, cycD1/CCND1↓, 1, cycE/CCNE↓, 1, Ki-67↓, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
IGF-1↓, 2, Ki-67↓, 1, TumCG↓, 1, TumCP↓, 1,
Migration(tgid=13) ⓘ
TumCMig↓, 1, TumMeta↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↓, 1, HIF-1↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2/PTGS2↓, 1, IL1β↓, 1, PGE2↓, 1, PSA↓, 1, TNF-α↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
ChemoSen↑, 2, CYP1A1↑, 1, eff↝, 1, selectivity↑, 1, Synergy↑, 3,
Clinical Biomarkers(tgid=22) ⓘ
EGFR↓, 1, HER2/EBBR2↓, 1, PSA↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 1, Risk↓, 2, TumVol↓, 1,
Ingredients & Constituents(tgid=25) ⓘ
Ingr↝, 1,
Total Targets: 55
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 1, Catalase↑, 1, GPx↑, 1, HDL↑, 1, HDL∅, 1, MDA↓, 1, ROS↓, 1, SAM-e↑, 1, SOD↑, 1, TAC↑, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
Insulin↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
ALAT↓, 1, ATP↝, 1, glucose↓, 1, LDL↓, 3, lipidLev↓, 3, NAD↝, 1, SIRT1↑, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
Akt2↓, 1, IKKα↓, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
BMPs↑, 1,
Migration(tgid=13) ⓘ
Ca+2↝, 1, MLC2/MYL9↝, 1, serineP↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
VCAM-1↓, 3,
Barriers & Transport(tgid=15) ⓘ
OCLN↝, 1, TJ↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
IL6↓, 1, Inflam↓, 5, NF-kB↓, 1, TNF-α↓, 4, VitD↑, 2,
Cellular Microenvironment(tgid=17) ⓘ
GGT/CD224↓, 1,
Synaptic & Neurotransmission(tgid=18) ⓘ
BDNF↑, 1,
Hormonal & Nuclear Receptors(tgid=20) ⓘ
cortisol↑, 1, DHT↑, 1, SHBG↓, 1, testos↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↑, 3, CompStab↝, 2, Dose?, 2, Dose↑, 2, Dose↝, 3, selectivity↑, 1, Synergy↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
ALAT↓, 1, AST↓, 1, BMD↑, 1, BP↓, 3, Calcium↑, 1, CRP↓, 2, HOMA↓, 1, hs-CRP↓, 7, IL6↓, 1, Mag↑, 1, TC↓, 2, TG/TAG↓, 2, VitD↑, 2,
Functional Outcomes(tgid=23) ⓘ
Analgesic↑, 1, AntiArt↑, 1, AntiCan↑, 3, AntiDiabetic↑, 3, cardioP↑, 3, chemoP↑, 1, chemoPv↑, 1, ChemoSideEff↓, 1, cognitive↑, 1, hepatoP↑, 2, memory↑, 1, neuroP↑, 2, Obesity↓, 1, Risk↓, 1, toxicity↝, 1,
Infection & Microbiome(tgid=24) ⓘ
AntiViral↑, 1, GutMicro↑, 3,
Ingredients & Constituents(tgid=25) ⓘ
Ingr?, 1, Ingr↑, 1, Ingr↝, 8,
Total Targets: 78
Scientific Paper Hit Count for: hs-CRP, High-sensitivity C-reactive protein
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:1 prod#:% Target#:848 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page